-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 18, CNN reported that the verdict of Elizabeth Holmes, founder of Theranos, was finally announced
.
Elizabeth Holmes, a Silicon Valley startup star who was once named a god for "blood cancer test", was sentenced to 11 years and 3 months
in prison for defrauding investors.
Elizabeth Holmes, who founded the super unicorn company Theranos, once claimed to be able to quickly detect whether a person has cancer, diabetes and other diseases by collecting a few drops of blood from the fingertip, which is considered to have "set off a revolution in disease diagnosis"
.
▲Source: Screenshot of CNN report
But this myth of "subverting medical diagnosis" was debunked
as early as 2015.
In October 2015, a Wall Street Journal report revealed that the results of the "drop blood cancer test" could not guarantee accuracy
.
Eventually, the blood testing company was dissolved
in 2018.
It is understood that most of Theranos' funding comes from high-profile investors, including former US Secretary of State George Schultz and Henry Kissinger, newspaper magnate Rupert Murdoch, and the family owner
of the US pharmacy chain Walgreens.
The endorsement of Holmes, Balvani and Theranos by people with such status and influence may have caused others to let their guard down and easily put out their real money
.
The vision that many diagnostic tests can be done using just a few drops of blood is revolutionary and taps into many people's innate aversion
to traditional blood tests.
This makes the idea particularly vulnerable to fraudsters — in September, a U.
S.
jury convicted Mark Schena of Arrayit of fraud, deceiving that his microarray technology could diagnose many allergies and even coronavirus
.
As early as 2014, the former State Food and Drug Administration and the former National Health and Family Planning Commission jointly suspended the project, on the grounds that the gene sequencer used in China, as well as related reagents and software, had not obtained the approval of the state for medical devices, which was an "illegal medical use" behavior
.
